BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31424918)

  • 1. N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.
    Watson MD; Lee JC
    Biochemistry; 2019 Sep; 58(35):3630-3633. PubMed ID: 31424918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence.
    Kang L; Janowska MK; Moriarty GM; Baum J
    PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the accessible conformations of N-terminal acetylated α-synuclein.
    Moriarty GM; Janowska MK; Kang L; Baum J
    FEBS Lett; 2013 Apr; 587(8):1128-38. PubMed ID: 23499431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
    Atieh TB; Roth J; Yang X; Hoop CL; Baum J
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural remodeling during amyloidogenesis of physiological Nα-acetylated α-synuclein.
    Gallea JI; Sarroukh R; Yunes-Quartino P; Ruysschaert JM; Raussens V; Celej MS
    Biochim Biophys Acta; 2016 May; 1864(5):501-10. PubMed ID: 26845568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
    Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.
    Bickle L; Hopwood JJ; Karageorgos L
    Biochim Biophys Acta Proteins Proteom; 2017 Mar; 1865(3):261-273. PubMed ID: 28007442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Mechanisms Determine α-Synuclein Fibril Morphology during Growth and Maturation.
    Sidhu A; Segers-Nolten I; Raussens V; Claessens MM; Subramaniam V
    ACS Chem Neurosci; 2017 Mar; 8(3):538-547. PubMed ID: 28292187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Properties of Human α-Synuclein Related to Propensity to Amyloid Fibril Formation.
    Fujiwara S; Kono F; Matsuo T; Sugimoto Y; Matsumoto T; Narita A; Shibata K
    J Mol Biol; 2019 Aug; 431(17):3229-3245. PubMed ID: 31181290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
    Lam HT; Graber MC; Gentry KA; Bieschke J
    Biochemistry; 2016 Feb; 55(4):675-85. PubMed ID: 26799377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
    Galvagnion C; Buell AK
    Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleation of α-Synuclein Amyloid Fibrils Induced by Cross-Interaction with β-Hairpin Peptides Derived from Immunoglobulin Light Chains.
    Heid LF; Kupreichyk T; Schützmann MP; Schneider W; Stoldt M; Hoyer W
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein.
    Ulamec SM; Maya-Martinez R; Byrd EJ; Dewison KM; Xu Y; Willis LF; Sobott F; Heath GR; van Oosten Hawle P; Buchman VL; Radford SE; Brockwell DJ
    Nat Commun; 2022 Aug; 13(1):4986. PubMed ID: 36008493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
    Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
    Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils.
    Yang X; Wang B; Hoop CL; Williams JK; Baum J
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
    O'Leary EI; Jiang Z; Strub MP; Lee JC
    J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.
    Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S
    Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of Cu
    Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
    Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.